SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001520138-23-000124
Filing Date
2023-03-06
Accepted
2023-03-06 08:00:12
Documents
12
Period of Report
2023-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20230303_8k.htm   iXBRL 8-K 31228
  Complete submission text file 0001520138-23-000124.txt   204319

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bivi-20230302.xsd EX-101.SCH 3239
3 XBRL LABEL FILE bivi-20230302_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bivi-20230302_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20230303_8k_htm.xml XML 3605
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 23707600
SIC: 2834 Pharmaceutical Preparations